Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Clinical trial NCT02844582 · TERMINATED
Trial details
- NCT number
- NCT02844582
- Sponsor
- University of California, Davis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2019-06-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.